The edible blue-green alga (cyanobacterium), Suizenji-nori, contained 143:8 AE 22:4 g of vitamin B 12 per 100 g dry weight of the alga (mean AE SE, n ¼ 4). A corrinoid compound was purified from the dried Suizenji-nori, and partially characterized. The silica gel 60 TLC and reversed-phase HPLC patterns of the purified corrinoid compound were not identical to those of true vitamin B 12 , but to those of pseudovitamin B 12 which is inactive for humans.
The usual dietary sources of vitamin B 12 (B 12 ) are animal food products (meat, milk, eggs and shellfish), but not plant food products. 1) Substantial amounts of B 12 , however, can be found in various edible algae. 2, 3) Our previous studies have demonstrated that true B 12 was the predominant cobamide of some eukaryotic algae, [4] [5] [6] [7] although pseudo-B 12 , an inactive corrinoid for humans, predominates in the prokaryotic, blue-green alga (cyanobacterium), spirulina.
8) It is still unclear whether other edible blue-green algae contain true B 12 or an inactive corrinoid compound.
Suizenji-nori (Aphanothece sacrum) is an edible bluegreen alga indigenous to Japan. The dried alga is used as an ordinary food item after being soaked in water as well as a nutritional supplementary food. The nutrition labeling of the algal product shows that the dried algal cells contain substantial amounts of B 12 . In this study, we purified and characterized a corrinoid compound from suizenji-nori and demonstrate the bioavailability of the algal corrinoids in humans.
After 2 g of the dried suizenji-nori had been suspended in 40 ml of distilled water and homogenized with a UD-200 ultrasonic disruptor (Tomy, Tokyo, Japan), total B 12 was extracted from the suspension while boiling in the acidic pH range and assayed by the microbiological method with Lactobacillus delbrueckii ATCC 7830 as described in the Japanese Standard Tables of Food Composition. 9) About 600 g of the dried suizenji-nori was added to 40 liters of a 50 mM acetate buffer at pH 4.8. Total B 12 was extracted from the suspension by boiling with KCN in the acidic pH range; 9) KCN was added to the suspension to a final concentration of 10 mM. The suspension was boiled for 30 min at 98 C in a draught chamber. The boiled suspension was left for several hours up to 30 C, and then centrifuged at 10;000 Â g for 10 min at 4 C. The supernatant fraction (about 20 liters) was put into a column (7 Â 100 cm) of Amberlite XAD-4 resin (Japan Organo Co., Tokyo, Japan), which had been washed with 10 liters of methanol and then equilibrated with distilled water, at room temperature in the dark. The column was washed with 10 liters of distilled water, and eluted with 10 liters of 80% (v/v) ethanol. The eluate was pooled, evaporated to dryness under reduced pressure, and dissolved in 100 ml of distilled water. The solution was loaded into a column (2:4 Â 30 cm) of Cosmosil 140C18-OPN (Nacalai Tesque, Kyoto, Japan), which had been washed with a 75% (v/v) ethanol solution and then equilibrated with distilled water, and eluted with 400 ml of a linear gradient (0-30% v/v) of ethanol. The B 12 -active fractions were pooled, evaporated to dryness under reduced pressure, and dissolved in a small amount of distilled water. The solution was further purified by the Cosmosil column (2:4 Â 15 cm) chromatography under the same conditions, except for eluting with 200 ml of a linear gradient (0-25% v/v) of ethanol. The B 12 -active fractions were pooled, evaporated to dryness under reduced pressure, and dissolved in a small amount of distilled water. The concentrated solution was put on to a silica gel 60 TLC sheet (Merck, Darmstadt, Germany) and developed with 2-propanol/ y To whom correspondence should be addressed. Tel/Fax: +81-857-31-5412; E-mail: watanabe@muses.tottori-u.ac.jp Biosci. Biotechnol. Biochem., 70 (12), [3066] [3067] [3068] 2006 Note NH 4 OH (28%)/water (7:1:2 v/v) as a solvent in the dark at room temperature. The red-colored spot on the TLC sheet was dried, collected, extracted with an 80% (v/v) methanol solution, evaporated to dryness under reduced pressure, and dissolved in 50 ml of distilled water. The solution was further purified by TLC under the same conditions. The concentrated solution was purified by HPLC with Shimadzu (Kyoto, Japan) apparatus (two LC-10ADvp pumps, a DGV-12A degasser, SCL-10Avp system controller, SPD-10Avvp ultraviolet-visible detector, CTO-10Avp column oven, 100-ml sample loop, and C-R6A chromatopac integrator). The sample (50 ml) was loaded into a reversed-phase HPLC column (Wakosil-II 5C18RS, 4:6 Â 150 mm; 5-mm particle size; Wako Pure Chemical Industries, Osaka, Japan) which had been equilibrated with a 20% (v/v) methanol solution containing 1% (v/v) acetic acid at 40 C. The flow rate was 1 ml/min. The corrinoid compound was isocratically eluted with the same solution, monitored by measuring the absorbance at 361 nm, and collected in 1-ml fractions. The final red-colored fraction was collected, evaporated to dryness under reduced pressure, dissolved in 20 ml of distilled water, and used as the purified corrinoid compound.
The B 12 concentration in the edible (blue-green) alga, suizenji-nori, was determined by the microbiological method. The dried alga contained 143:8 AE 22:4 mg of B 12 per 100 g dry weight of the alga (mean AE SE, n ¼ 4). A similar B 12 concentration (94 mg) has been shown in the nutrition labeling of the algal product.
To evaluate whether the B 12 activity detected in the suizenji-nori extract was derived from true B 12 nor not, a corrinoid compound was purified and partially characterized. The final purified preparation gave a single redcolored spot by silica gel 60 TLC and a single peak by reversed-phase HPLC, indicating that the corrinoid compound had been purified to homogeneity.
The ultraviolet-visible spectrum of the compound purified from the suizenji-nori showed a typical absorption of cobalt-containing corrinoid (Fig. 1) ; max nm (absorbance) was at 548.0 (0.350), 518.0 (0.334), and 360.0 (1.366). The purified corrinoid compound, authentic B 12 , and cyanocobamides (pseudo-B 12 and 5-hydroxybenzimidazolyl, and benzimidazolyl cyanocobamides; all kindly provided by Dr. E. Stupperich, Ulm University, Germany) were compared by silica gel 60 TLC and reversed-phase HPLC ( Table 1 ). The R f values (0.14 and 0.48 in solvents I and II, respectively, by TLC) for the purified compound were identical to those for authentic pseudo-B 12 , whose retention time (6.7 min by HPLC) was also identical to that of the purified compound. The authentic pseudo-B 12 (identified by Dr. Stupperich) has been independently analyzed with 1 H-NMR spectroscopy by ourselves (unpublished data); the spectrum of the authentic compound was identical to that of the cited reference.
10) The authentic pseudo-B 12 also gave identical patterns of TLC and HPLC to those of the main Spirulina corrinoid compound which has been identified as pseudo-B 12 .
8) The TLC and HPLC patterns of the compound purified from suizenji-nori, pseudo-B 12 purified from Spirulina tablets, and authentic pseudo-B 12 are shown in Fig. 2 . These results indicate that the red-colored compound purified from suizenji-nori was not true B 12 , but pseudo-B 12 that is inactive for humans. No further detailed information on the purified compound is available because only a small amount of the purified sample was obtained (for the NMR study).
These results indicate that suizenji-nori is not suitable for use as a B 12 source, especially for vegetarians.
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